These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 26487665

  • 1. Interrelationship between electrocardiographic left ventricular hypertrophy, QT prolongation, and ischaemic stroke: the REasons for Geographic and Racial Differences in Stroke Study.
    O'Neal WT, Howard VJ, Kleindorfer D, Kissela B, Judd SE, McClure LA, Cushman M, Howard G, Soliman EZ.
    Europace; 2016 May; 18(5):767-72. PubMed ID: 26487665
    [Abstract] [Full Text] [Related]

  • 2. Inter-relationship between electrocardiographic left ventricular hypertrophy and QT prolongation as predictors of increased risk of mortality in the general population.
    Soliman EZ, Shah AJ, Boerkircher A, Li Y, Rautaharju PM.
    Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):400-6. PubMed ID: 24762807
    [Abstract] [Full Text] [Related]

  • 3. Prolonged corrected QT interval is predictive of future stroke events even in subjects without ECG-diagnosed left ventricular hypertrophy.
    Ishikawa J, Ishikawa S, Kario K.
    Hypertension; 2015 Mar; 65(3):554-60. PubMed ID: 25534703
    [Abstract] [Full Text] [Related]

  • 4. Electrocardiographic Left Ventricular Hypertrophy as a Predictor of Cardiovascular Disease Independent of Left Ventricular Anatomy in Subjects Aged ≥65 Years.
    Leigh JA, O'Neal WT, Soliman EZ.
    Am J Cardiol; 2016 Jun 01; 117(11):1831-5. PubMed ID: 27067620
    [Abstract] [Full Text] [Related]

  • 5. Electrocardiographic and Echocardiographic Left Ventricular Hypertrophy in the Prediction of Stroke in the Elderly.
    O'Neal WT, Almahmoud MF, Qureshi WT, Soliman EZ.
    J Stroke Cerebrovasc Dis; 2015 Sep 01; 24(9):1991-7. PubMed ID: 26153509
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
    Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Wedel H, Lindholm LH, Dahlöf B, LIFE Study Investigators.
    JAMA; 2004 Nov 17; 292(19):2343-9. PubMed ID: 15547161
    [Abstract] [Full Text] [Related]

  • 8. Impact of left ventricular hypertrophy on QT prolongation and associated mortality.
    Haugaa KH, Bos JM, Borkenhagen EJ, Tarrell RF, Morlan BW, Caraballo PJ, Ackerman MJ.
    Heart Rhythm; 2014 Nov 17; 11(11):1957-65. PubMed ID: 24956189
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Four ECG left ventricular hypertrophy criteria and the risk of cardiovascular events and mortality in patients with vascular disease.
    van Kleef MEAM, Visseren FLJ, Vernooij JWP, Nathoe HM, Cramer MM, Bemelmans RHH, van der Graaf Y, Spiering W, SMART-study group.
    J Hypertens; 2018 Sep 17; 36(9):1865-1873. PubMed ID: 29878973
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Interrelation Between Electrocardiographic Left Atrial Abnormality, Left Ventricular Hypertrophy, and Mortality in Participants With Hypertension.
    Ahmad MI, Mujtaba M, Anees MA, Li Y, Soliman EZ.
    Am J Cardiol; 2019 Sep 15; 124(6):886-891. PubMed ID: 31324356
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Changes in electrocardiographic left ventricular hypertrophy and risk of major cardiovascular events in isolated systolic hypertension: the LIFE study.
    Larstorp AC, Okin PM, Devereux RB, Olsen MH, Ibsen H, Dahlöf B, Kjeldsen SE, Wachtell K.
    J Hum Hypertens; 2011 Mar 15; 25(3):178-85. PubMed ID: 20505749
    [Abstract] [Full Text] [Related]

  • 16. Prognostic impact of baseline and serial changes in electrocardiographic left ventricular hypertrophy in resistant hypertension.
    Salles GF, Cardoso CR, Fiszman R, Muxfeldt ES.
    Am Heart J; 2010 May 15; 159(5):833-40. PubMed ID: 20435193
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
    Greve AM, Boman K, Gohlke-Baerwolf C, Kesäniemi YA, Nienaber C, Ray S, Egstrup K, Rossebø AB, Devereux RB, Køber L, Willenheimer R, Wachtell K.
    Circulation; 2012 Jan 17; 125(2):346-53. PubMed ID: 22147903
    [Abstract] [Full Text] [Related]

  • 19. Relation of QT interval and QT dispersion to regression of echocardiographic and electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan Intervention For Endpoint Reduction (LIFE) study.
    Oikarinen L, Nieminen MS, Toivonen L, Viitasalo M, Wachtell K, Papademetriou V, Jern S, Dahlöf B, Devereux RB, Okin PM, LIFE Study Investigators.
    Am Heart J; 2003 May 17; 145(5):919-25. PubMed ID: 12766755
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.